Patent ID: 6437094
Filing Date: 2002-08-20
Classification: A61K,A61P,C07K,Y02P

Abstract:
A method of inhibiting &agr;v&bgr;3 â€”integrin mediated cell attachment to an RGD-containing ligand in a mammal in need thereof comprising administering to said mammal a compound of formula I where n is 0, 1, or 2, and Arg is the amino acid L-Arginine, Gly is the amino acid Glycine and Asp is the amino acid L-Aspartic acid or a salt thereof, or a racemate, a single enantiomer or diasterosisomer thereof, for a time and under conditions effective to inhibit &agr;v&bgr;3â€”integrin mediated cell attachment to an RGD-containing ligand.